Ali Choucair
Neurology · Austin, TXNPI 1063426971
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 35.1% of the total. That places this record below the midpoint for neurology clinicians in TX, where the typical reported total is $2,170.
Across 118 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$674
- UCB, Inc.$213
- Amgen$200
- Eisai Inc.$115
- Akcea Therapeutics, Inc.$100
- AstraZeneca$70
- plus $549 from 16 others
What the payments were for
- Speaking & faculty fees$623%
- Food & beverage$1,85997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 44 | $674 |
| UCB, Inc. | 12 | $213 |
| Amgen | 13 | $200 |
| Eisai Inc. | 7 | $115 |
| Akcea Therapeutics, Inc. | 3 | $100 |
| AstraZeneca | 4 | $70 |
| CSL Behring | 3 | $65 |
| Novartis | 4 | $64 |
| Acorda Therapeutics, Inc | 4 | $62 |
| Avanir Pharmaceuticals, Inc. | 5 | $60 |
| Acadia Pharmaceuticals Inc | 3 | $47 |
| Promius Pharma LLC | 3 | $42 |
| Johnson & Johnson | 3 | $36 |
| Seagen Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| MDD US Operations, LLC | 1 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Travere Therapeutics, Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$1,922 in reported general payments places this provider in the 45th percentile of 1,246 neurology providers in Texas.
Other neurology in Austin
- Elliot FrohmanAustin$381K
- Krishna PokalaAustin$143K
- Subhashie SarathkumaraAustin$129K
- David MorledgeAustin$128K
- Stephanie VertreesAustin$119K
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Mirla AvilaLubbock$1.3M
- Michael SoileauGeorgetown$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.